Unrestricted somatic stem cells as vehicle for nerve growth factor gene transfer

Neurological Research

Volumn 35, Issue 6, 2013, Pages 553-560

  Jalali, Hanieh ^a   Parivar, Kazem ^a   Nabiuni, Mohammad ^a   Soleimani, Masoud ^b  

^a KHARAZMI UNIVERSITY   (Iran)

^b TARBIAT MODARES UNIVERSITY   (Iran)

Author keywords

BetaNGF; Gene therapy; Lentivirus; USSC

Indexed keywords

BETA TUBULIN; LENTIVIRUS VECTOR; MICROTUBULE ASSOCIATED PROTEIN 2; NERVE GROWTH FACTOR BETA SUBUNIT; NEURON SPECIFIC ENOLASE; PROTEIN S100B;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; FLUORESCENCE MICROSCOPY; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; NONHUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SOMATIC GENE THERAPY; UMBILICAL CORD BLOOD;

ADULT STEM CELLS; ANIMALS; CELL SURVIVAL; COCULTURE TECHNIQUES; FETAL BLOOD; GENE TRANSFER TECHNIQUES; HEK293 CELLS; HUMANS; NERVE GROWTH FACTOR; PC12 CELLS; RATS;

EID: 84879476779     PISSN: 01616412     EISSN: 17431328     Source Type: Journal    
DOI: 10.1179/1743132813Y.0000000176     Document Type: Article

References (25)

1. Bartkowska K, Turlejski K, Djavadian RL. Neurotrophins and their receptors in early development of the mammalian nervous system. Acta Neurobiol Exp (Wars). 2010;70:454-67.
2. Terenghi G. Peripheral nerve regeneration and neurotrophic factors. J Anat. 1999;194 (Pt 1):1-14.
3. Piirsoo M, Kaljas A, Tamm K, Timmusk T. Expression of NGF and GDNF family members and their receptors during peripheral nerve development and differentiation of Schwann cells in vitro. Neurosci Lett. 2010;469:135-40.
4. Mufson EJ, Counts SE, Perez SE, Ginsberg SD. Cholinergic system during the progression of Alzheimer's disease: therapeutic implications. Expert Rev Neurother. 2008;8:1703-18.
5. De Rosa R, Garcia AA, Braschi C, Capsoni S, Maffei L, Berardi N, et al. Intranasal administration of nerve growth factor (NGF) rescues recognition memory deficits in AD11 anti-NGF transgenic mice. Proc Natl Acad Sci USA. 2005;102:3811-6.
6. Bishop KM, Hofer EK, Mehta A, Ramirez A, Sun L, Tuszynski M, et al. Therapeutic potential of CERE-110 (AAV2-NGF): targeted, stable, and sustained NGF delivery and trophic activity on rodent basal forebrain cholinergic neurons. Exp Neurol. 2008;211:574-84.
7. Wyman T, Rohrer D, Kirigiti P, Nichols H, Pilcher K, Nilaver G, et al. Promoter-activated expression of nerve growth factor for treatment of neurodegenerative diseases. Gene Ther. 1999;6:1648-60.
8. Tuszynski MH. Growth-factor gene therapy for neurodegenerative disorders. Lancet Neurol. 2002;1:51-57.
9. Hwang DH, Jeong SR, Kim BG. Gene transfer mediated by stem cell grafts to treat CNS injury. Expert Opin Biol Ther. 2011;11:1599-1610.
10. Kogler G, Sensken S, Airey JA, Trapp T, Muschen M, Feldhahn N, et al. A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J Exp Med. 2004;200:123-135.
11. Iwasaki H, Kawamoto A, Willwerth C, Horii M, Oyamada A, Akimaru H, et al. Therapeutic potential of unrestricted somatic stem cells isolated from placental cord blood for cardiac repair post myocardial infarction. Arterioscler Thromb Vasc Biol. 2009;29:1830-5.
12. Schira J, Gasis M, Estrada V, Hendricks M, Schmitz C, Trapp T, et al. Significant clinical, neuropathological and behavioural recovery from acute spinal cord trauma by transplantation of a well-defined somatic stem cell from human umbilical cord blood. Brain. 2012;135:431-46.
13. Trapp T, Kogler G, El-Khattouti A, Sorg RV, Besselmann M, Focking M, et al. Hepatocyte growth factor/c-MET axismediated tropism of cord blood-derived unrestricted somatic stem cells for neuronal injury. J Biol Chem. 2008;283:32244-53.
14. Iwaniuk KM, Schira J, Weinhold S, Jung M, Adjaye J, Muller HW, et al. Network-like impact of MicroRNAs on neuronal lineage differentiation of unrestricted somatic stem cells from human cord blood. Stem Cells Dev. 2011;20:1383-94.
15. Fallahi-Sichani M, Soleimani M, Najafi SM, Kiani J, Arefian E, Atashi A. In vitro differentiation of cord blood unrestricted somatic stem cells expressing dopamine-associated genes into neuron-like cells. Cell Biol Int. 2007;31:299-303.
16. Longhi L, Watson DJ, Saatman KE, Thompson HJ, Zhang C, Fujimoto S, et al. Ex vivo gene therapy using targeted engraftment of NGF-expressing human NT2N neurons attenuates cognitive deficits following traumatic brain injury in mice. J Neurotrauma. 2004;21:1723-36.
17. Lee HJ, Lim IJ, Park SW, Ko YB, Kim SU. Human neural stem cells genetically modified to express human nerve growth factor (NGF) gene restore cognition in mouse with ibotenic acid-induced cognitive dysfunction. Cell Transplant 2012. [Epub ahead of print]
18. Kao S, Jaiswal RK, Kolch W, Landreth GE. Identification of the mechanisms regulating the differential activation of the mapk cascade by epidermal growth factor and nerve growth factor in PC12 cells. J Biol Chem. 2001;276:18169-77.
19. Hafizi M, Bakhshandeh B, Soleimani M, Atashi A. Exploring the enkephalinergic differentiation potential in adult stem cells for cell therapy and drug screening implications. In Vitro Cell Dev Biol Anim. 2012;48:562-9.
20. Tuszynski MH, Thal L, Pay M, Salmon DP, U HS, Bakay R, et al. A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease. Nat Med. 2005;11:551-5.
21. Kobayashi H, Gleich GJ, Butterfield JH, Kita H. Human eosinophils produce neurotrophins and secrete nerve growth factor on immunologic stimuli. Blood. 2002;99:2214-20.
22. Snyder BR, Boulis NM, Federici T. Viral vector-mediated gene transfer for CNS disease. Expert Opin Biol Ther. 2010;10:381-94.
23. Ali H, Bahbahani H. Umbilical cord blood stem cells - potential therapeutic tool for neural injuries and disorders. Acta Neurobiol Exp (Wars). 2010;70:316-24.
24. Snyder EY, Senut MC. The use of nonneuronal cells for gene delivery. Neurobiol Dis. 1997;4:69-102.
25. Joers VL, Emborg ME. Preclinical assessment of stem cell therapies for neurological diseases. ILAR J. 2009;51:24-41.